Study of Cipterbin®, Used Alone or With Vinorelbine in Patients With HER2/Neu-overexpressed Metastatic Breast Cancer

计划入组 109 人 · 首次发布于 2011 年 9 月 23 日

Clinical Study of Recombinant Anti-HER2 Humanized Monoclonal Antibody for Injection

计划入组 132 人 · 首次发布于 2019 年 11 月 20 日

Discordant HER2/Neu Status of Breast Cancer.

计划入组 105 人 · 首次发布于 2013 年 9 月 5 日

Ii-Key-HER2,neu

li-Key-HER2/neu

HER2/neu peptide vaccine

Pathway Therapeutics, Inc.

United States

Cambridge Antibody Technology

New Zealand

Latticon Antibody Therapeutics, Inc

United States

FDA Approves Roche's Companion Diagnostic for HER2-Targeted Therapy in Biliary Tract Cancer

Roche Advances in TIGIT Immunotherapy and AI-Driven Biomarker Development Signal Strategic Shift in Precision Oncology

FDA Approves Roche's PATHWAY HER2 Test as Companion Diagnostic for Biliary Tract Cancer